Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Viewpoint: Origin of Sars-Cov-2 Publisher Pubmed



Lundstrom K1 ; Seyran M2, 3 ; Pizzol D4 ; Adadi P5 ; Elaziz TMA6, 7 ; Hassan SS8 ; Soares A6 ; Kandimalla R9, 10 ; Tambuwala MM11 ; Aljabali AAA12 ; Azad GK13 ; Choudhury PP14 ; Uversky VN15 ; Sherchan SP16 Show All Authors
Authors
  1. Lundstrom K1
  2. Seyran M2, 3
  3. Pizzol D4
  4. Adadi P5
  5. Elaziz TMA6, 7
  6. Hassan SS8
  7. Soares A6
  8. Kandimalla R9, 10
  9. Tambuwala MM11
  10. Aljabali AAA12
  11. Azad GK13
  12. Choudhury PP14
  13. Uversky VN15
  14. Sherchan SP16
  15. Uhal BD17
  16. Rezaei N18, 19
  17. Brufsky AM20
Show Affiliations
Authors Affiliations
  1. 1. PanTherapeutics, Lutry, CH1095, Switzerland
  2. 2. Doctoral Studies in Natural Sciences and Technology SPL44, University of Vienna, Vienna, 1010, Austria
  3. 3. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Vienna, Vienna, 1010, Austria
  4. 4. Department of Global Health, Italian Agency for Development Cooperation-Khartoum, Al Amarat, 111111, Sudan
  5. 5. Department of Food Science, University of Otago, Dunedin, 9054, New Zealand
  6. 6. Department of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, San Antonio, 78229-3900, TX, United States
  7. 7. Zoology Department, Faculty of Science, Minia University, El-Minia, 61519, Egypt
  8. 8. Department of Mathematics, Pingla Thana Mahavidyalaya, Maligram, Paschim Medinipur, 721140, West Bengal, India
  9. 9. Department of Applied Biology, CSIR, Indian Institute of Chemical Technology, Tarnaka, Hyderabad, 500007, India
  10. 10. Department of Biochemistry, Kakatiya Medical College/MGM-Hospital, Hyderabad, 500007, India
  11. 11. School of Pharmacy and Pharmaceutical Science, Ulster University, Coleraine, Northern Ireland, BT52 1SA, United Kingdom
  12. 12. Department of Pharmaceutical Sciences, Faculty of Pharmacy, Yarmouk University, Irbid, 21163, Jordan
  13. 13. Department of Zoology, Patna University, Patna, 800005, Bihar, India
  14. 14. Applied Statistics Unit, Indian Statistical Institute, Kolkata, 700108, West Bengal, India
  15. 15. Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, 33612, FL, United States
  16. 16. Department of Environmental Health Sciences, Tulane University, New Orleans, 70112, LA, United States
  17. 17. Department of Physiology, Michigan State University, East Lansing, 48824, MI, United States
  18. 18. Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, 1419733151, Iran
  19. 19. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, 1419733151, Iran
  20. 20. UPMC Hillman Cancer Center, Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh School of Medicine, Pittsburgh, 15213, PA, United States

Source: Viruses Published:2020


Abstract

The origin of the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) virus causing the COVID-19 pandemic has not yet been fully determined. Despite the consensus about the SARS-CoV-2 origin from bat CoV RaTG13, discrepancy to host tropism to other human Coronaviruses exist. SARS-CoV-2 also possesses some differences in its S protein receptor-binding domain, glycan-binding N-terminal domain and the surface of the sialic acid-binding domain. Despite similarities based on cryo-EM and biochemical studies, the SARS-CoV-2 shows higher stability and binding affinity to the ACE2 receptor. The SARS-CoV-2 does not appear to present a mutational hot spotas only the D614G mutation has been identified from clinical isolates. As laboratory manipulation is highly unlikely for the origin of SARS-CoV-2, the current possibilities comprise either natural selection in animal host before zoonotic transfer or natural selection in humans following zoonotic transfer. In the former case, despite SARS-CoV-2 and bat RaTG13 showing 96% identity some pangolin Coronaviruses exhibit very high similarity to particularly the receptor-binding domain of SARS-CoV-2. In the latter case, it can be hypothesized that the SARS-CoV-2 genome has adapted during human-to-human transmission and based on available data, the isolated SARS-CoV-2 genomes derive from a common origin. Before the origin of SARS-CoV-2 can be confirmed additional research is required. © 2020 by the authors.